<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02205229</url>
  </required_header>
  <id_info>
    <org_study_id>Medimix Pharm-03</org_study_id>
    <nct_id>NCT02205229</nct_id>
  </id_info>
  <brief_title>Compounded Pain Preparation Absorption Study</brief_title>
  <acronym>ComPASS</acronym>
  <official_title>Compounded Pain Preparation Absorption Study (ComPPAS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medimix Specialty Pharmacy, LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medimix Specialty Pharmacy, LLC</source>
  <brief_summary>
    <textblock>
      Single center, prospective, observational study to assess serum concentration of ingredients
      used in multi-ingredient, topical compounded medications from Medimix Specialty Pharmacy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Single center, prospective, observational, open-label, cohort study of participants that
      receive a combination topical pain medication from Medimix Specialty Pharmacy with no
      comparator group designed to assess serum concentration of ingredients used in
      multi-ingredient, topical compounded medications.
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Poor enrollment
  </why_stopped>
  <start_date>August 2014</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">August 2015</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>Serum concentration of ingredients used in multi-ingredient, topical compounded medications</measure>
    <time_frame>1 Month</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Patients receiving a topical compounded medication</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Multi-ingredient, topical compounded medications</intervention_name>
    <arm_group_label>Patients receiving a topical compounded medication</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient between the ages of 30 and &lt;65 years old not taking concomitant medications that
        may interact with study ingredients.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants must apply and consistently use the supplied cream for 1 month at a
             prescribed

          -  Participants must be â‰¥ 30 and &lt;65 years of age

          -  Participants must be able to provide sound written and verbal informed consent

          -  Participants must be diagnosed with an ICD9 code indicative of chronic pain

        Exclusion Criteria:

          -  Participants must not have prior hypersensitivity or adverse events to any of the
             components in the customized prescription

          -  Participants must not be pregnant or breastfeeding

          -  Participants must not have used any study drug greater than 180 days from the day of
             Screening

          -  Participants must not be utilizing medications that may interact with those being used
             in the topical formulation as determined by the PI

          -  Participants must not be using any systemic medications that may influence drug serum
             concentrations of ingredients being used in the topical compound. These include
             medications from the same class of studied drugs or drugs that may falsely increase or
             decrease serum levels of the study drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Medimix Specialty Pharmacy</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 29, 2014</study_first_submitted>
  <study_first_submitted_qc>July 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 31, 2014</study_first_posted>
  <last_update_submitted>May 15, 2015</last_update_submitted>
  <last_update_submitted_qc>May 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

